SXTC icon

China SXT Pharmaceuticals

8 hedge funds and large institutions have $264K invested in China SXT Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.

Holders
8
Holders Change
Holders Change %
0%
% of All Funds
0.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
2
Reduced
1
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$165K 254,283 +254,283 New
VF
2
Virtu Financial
New York
$28K 42,993 +5,470 +15%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$17K 26,642
Renaissance Technologies
4
Renaissance Technologies
New York
$14K 21,400 +21,400 New
Two Sigma Advisers
5
Two Sigma Advisers
New York
$13K 20,400 +20,400 New
Squarepoint
6
Squarepoint
New York
$12K 18,115 -1,259 -6%
UBS Group
7
UBS Group
Switzerland
$12K 18,613 +18,613 New
Bank of America
8
Bank of America
North Carolina
$3K 4,079 +2,952 +262%
HF
9
HRT Financial
New York
-83,890 Closed
Citadel Advisors
10
Citadel Advisors
Florida
-10,754 Closed
TSS
11
Two Sigma Securities
New York
-10,355 Closed
HI
12
Hudock Inc
Pennsylvania
-4,000 Closed
CFGS
13
Concourse Financial Group Securities
Alabama